Brindle & Bay Financial Advisors LLC acquired a new stake in shares of Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,931 shares of the company’s stock, valued at approximately $699,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Kimberly-Clark by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 40,846,734 shares of the company’s stock valued at $4,121,027,000 after acquiring an additional 315,981 shares in the last quarter. State Street Corp raised its holdings in shares of Kimberly-Clark by 5.0% during the third quarter. State Street Corp now owns 20,830,890 shares of the company’s stock valued at $2,615,382,000 after acquiring an additional 997,397 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Kimberly-Clark by 50.4% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 7,839,572 shares of the company’s stock valued at $790,934,000 after acquiring an additional 2,628,206 shares in the last quarter. Capital World Investors raised its holdings in shares of Kimberly-Clark by 0.3% during the third quarter. Capital World Investors now owns 4,940,945 shares of the company’s stock valued at $614,357,000 after acquiring an additional 14,306 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Kimberly-Clark by 0.3% during the third quarter. Northern Trust Corp now owns 3,890,193 shares of the company’s stock valued at $483,707,000 after acquiring an additional 9,951 shares in the last quarter. Institutional investors own 76.29% of the company’s stock.
Insider Transactions at Kimberly-Clark
In other Kimberly-Clark news, VP Andrew Scribner sold 3,049 shares of the stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $104.29, for a total value of $317,980.21. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.75% of the company’s stock.
Kimberly-Clark Price Performance
Kimberly-Clark (NASDAQ:KMB – Get Free Report) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.81 by $0.05. The business had revenue of $4.08 billion during the quarter, compared to the consensus estimate of $4.11 billion. Kimberly-Clark had a return on equity of 170.48% and a net margin of 11.73%.The firm’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.50 earnings per share. Research analysts predict that Kimberly-Clark Corporation will post 7.47 earnings per share for the current fiscal year.
Kimberly-Clark Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 2nd. Shareholders of record on Friday, March 6th were issued a $1.28 dividend. This represents a $5.12 dividend on an annualized basis and a yield of 5.2%. This is a positive change from Kimberly-Clark’s previous quarterly dividend of $1.26. The ex-dividend date was Friday, March 6th. Kimberly-Clark’s dividend payout ratio is currently 84.35%.
Analyst Upgrades and Downgrades
KMB has been the subject of a number of recent analyst reports. Barclays decreased their target price on Kimberly-Clark from $105.00 to $99.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Citigroup decreased their target price on Kimberly-Clark from $95.00 to $90.00 and set a “sell” rating for the company in a report on Wednesday, January 14th. Piper Sandler decreased their target price on Kimberly-Clark from $133.00 to $114.00 and set an “overweight” rating for the company in a report on Friday, March 13th. Zacks Research downgraded Kimberly-Clark from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Kimberly-Clark from $110.00 to $109.00 and set a “hold” rating for the company in a report on Monday, March 30th. Four research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $114.86.
Check Out Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Company Profile
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
Featured Stories
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
